Zymeworks, J&J in bispecific antibodies deal

Zymeworks Inc. (NYSE:ZYME; TSX:ZYME) granted the Janssen Biotech Inc. unit of Johnson & Johnson (NYSE:JNJ) worldwide

Read the full 160 word article

User Sign In